Picketa Systems Raises $2.1M as Fertilizer Costs Squeeze North American Growers

PotatoPro reports that Picketa Systems closed an oversubscribed $2.1 million funding round led by Tall Grass Ventures, with new investors BDC Seed Fund, Verdex Capital, and Skull Diamond & Heart Capital joining returning backers NBIF, Koan Capital, and East Valley Ventures. The timing is not incidental to the pitch: the source material cites fertilizer prices up 49% and notes that seventy percent of American farmers cannot afford all the inputs they need this season. Wilson Acton, Managing Partner at Tall Grass Ventures, said the current fertilizer pricing dynamic is "only a further tailwind to approach application decisions with real-time data instead of guesswork or routine." That framing positions Picketa's technology less as a novel gadget and more as a cost-control tool for a moment when input budgets are under visible pressure.

The product at the center of the round is LENS (Leaf Evaluated Nutrient System), a portable device described as delivering readings on all essential macro and micronutrients in under a minute directly in the field. Results feed into Fieldbook, Picketa's crop management platform, giving agronomists and growers data while decisions are still actionable. According to the source material, replacing guesswork with real-time nutrient insight could let growers save up to 20% on in-season fertilizer expenditure. That is a meaningful claim given the reported 49% input price increase, though it is presented as a potential saving rather than a documented average outcome.

Picketa's roots are in potato agronomy: Wilson Acton described watching the LENS technology develop "from an early concept in New Brunswick potatoes to this stage across multiple crops in multiple geographies." The company now reports over 45 ag retailers using LENS to support in-season fertility recommendations, with hundreds of their farmer customers able to view crop nutrient conditions in real time. Mark Smith of BDC Seed Fund and Steve Koeckhoven of Verdex Capital both framed the investment case around trust and reliability in the field rather than novelty, language consistent with a company moving from pilot use toward routine adoption by retailers who advise growers directly.

LENS now supports potatoes, corn, canola, soybeans, and wheat, a set of crops PotatoPro's source material says together account for over 70% of crop acres in North America, with soybeans and wheat the most recent additions. That expansion followed what the source describes as strong pilot activity in 2025, when growers collected thousands of samples to validate the platform across crops affected by fertilizer volatility. Among early soybean adopters is Chris Weaver, described as the world record holder for soybean yield, who is trialing the platform during the 2026 season. Weaver said the ability to get results instead of waiting forty-eight hours "completely changes how quickly we can react to problems in the field." Picketa was also named one of five companies selected for Farm Credit Canada's Agriculture Innovation, Validation and Adoption Network, with LENS set to be tested across four validation hubs — Area X.O, EMILI, Innovation Farms Ontario, and Olds College — building on existing calibration work with the University of Guelph, University of Missouri, University of Nebraska-Lincoln, and Cornell AgriTech. FCC has stated that agricultural technology adoption could boost farmer incomes by $30 billion over the next decade, according to the source material.

Xavier Hebert-Couturier, CEO and Co-Founder of Picketa Systems, framed the funding within a longer horizon, saying he believes that within ten years, advances in crop sensing, specialized inputs, and autonomous vehicles will "close the fertilizer loop entirely," with systems sensing crop needs, prescribing applications, and applying them automatically. That vision extends well beyond the current LENS product, which still requires a handheld device and a human operator walking the field. The gap between the ten-year automation vision and the current under-a-minute manual reading is worth noting as a measure of how much infrastructure — sensing, prescription software, and application machinery — would still need to be built and integrated.